Outlook Therapeutics, Inc. (OTLK)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 4 signals for Outlook Therapeutics, Inc.. Most notable: 2026-08-12: Sukhtian Ghiath M.; GMS Ventures & Investments (director) bought $2.5M of stock; 2026-07-24: Filed 8-K disclosing director or officer change; 2026-08-27: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseSukhtian Ghiath M.; GMS Ventures & Investments (director) bought $2.5M of stock
- Insider purchaseSukhtian Faisal Ghiath (director) bought $100k of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider buying cluster3 insiders bought $5.3M within 14 days
- Insider purchaseGMS Ventures & Investments (director) bought $5.0M of stock
- Insider purchaseSukhtian Faisal Ghiath (director) bought $50k of stock
- Insider purchaseHILZINGER KURT J (director) bought $176k of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-14 | Jahr Robert Charles | director | P | 151,515 | — | — |
| 2026-08-14 | KENYON LAWRENCE A | director | P | 101,010 | — | — |
| 2026-08-12 | Sukhtian Ghiath M.; GMS Ventures & Investments | director | P | 2,525,252 | 0.99 | $2,499,999 |
| 2026-07-29 | Sukhtian Faisal Ghiath | director | P | 95,398 | 1.05 | $99,996 |
| 2026-06-02 | Haddadin Yezan Munther | director | P | 29,000 | 0.83 | $24,070 |
| 2026-06-02 | Haddadin Yezan Munther | director | P | 29,000 | 0.83 | $24,145 |
| 2026-05-28 | GMS Ventures & Investments | director | P | 8,539,709 | 0.59 | $5,038,428 |
| 2026-05-28 | Sukhtian Ghiath M.; GMS Ventures & Investments | director | P | 8,539,709 | 0.59 | $5,000,000 |
| 2026-05-27 | Sukhtian Faisal Ghiath | director | P | 122,174 | 0.41 | $50,091 |
| 2026-05-27 | Sukhtian Faisal Ghiath | director | P | 122,174 | 0.41 | $50,006 |
| 2026-05-26 | Haddadin Yezan Munther | director | P | 34,000 | 0.44 | $14,960 |
| 2026-05-26 | THURMAN RANDY H | director | P | 5,000 | 0.43 | $2,150 |
| 2026-05-26 | HILZINGER KURT J | director | P | 400,000 | 0.44 | $176,000 |
| 2026-05-26 | Haddadin Yezan Munther | director | P | 34,000 | 0.44 | $14,960 |
| 2026-05-26 | THURMAN RANDY H | director | P | 5,000 | 0.43 | $2,145 |
| 2026-05-26 | HILZINGER KURT J | director | P | 400,000 | 0.44 | $176,520 |
| 2025-05-27 | Sukhtian Ghiath M. | director | A | 4,285,714 | 1.4 | $6,000,000 |
| 2025-05-27 | Sukhtian Ghiath M.; GMS Ventures & Investments | director | A | 4,285,714 | 1.4 | $6,000,000 |
| 2025-01-17 | Sukhtian Ghiath M. | director | M | 3,458,571 | 2.51 | $8,681,013 |
| 2025-01-17 | Sukhtian Ghiath M.; GMS Ventures & Investments | director | M | 3,458,571 | 2.51 | $8,681,013 |
| 2024-09-26 | KENYON LAWRENCE A | director | P | 5,000 | 5.69 | $28,450 |
| 2024-09-26 | KENYON LAWRENCE A | director | P | 5,000 | 5.69 | $28,446 |
| 2024-04-15 | Syntone Ventures LLC | ten percent owner | P | 714,286 | — | — |
| 2024-03-28 | Haddadin Yezan Munther | director | P | 1,882 | 11.82 | $22,242 |
| 2024-03-18 | Sukhtian Ghiath M.; GMS Ventures & Investments | director | A | 2,305,714 | — | — |
| 2024-03-07 | Evanson Jeff | officer | P | 62,484 | 0.42 | $26,243 |
| 2023-04-20 | Dagnon Terry | officer | S | 520,000 | 1.14 | $590,200 |
| 2023-01-20 | Evanson Jeff | officer | S | 267,000 | 1.11 | $296,370 |
| 2023-01-19 | Evanson Jeff | officer | S | 103,255 | 1.22 | $125,971 |
| 2023-01-18 | Evanson Jeff | officer | S | 33,738 | 1.25 | $42,173 |
| 2023-01-17 | Evanson Jeff | officer | S | 27,162 | 1.31 | $35,582 |
| 2022-12-28 | Sukhtian Ghiath M.; GMS Ventures & Investments | director | A | 14,230,418 | 0.88 | $12,499,999 |
| 2022-10-07 | Sukhtian Faisal Ghiath | director | P | 30,000 | 1.29 | $38,700 |
| 2022-10-07 | Haddadin Yezan Munther | director | P | 3,600 | 1.27 | $4,572 |
| 2022-10-06 | Haddadin Yezan Munther | director | P | 29,743 | 1.29 | $38,368 |
| 2022-10-05 | HILZINGER KURT J | director | P | 15,662 | 1.23 | $19,264 |
| 2022-10-04 | HILZINGER KURT J | director | P | 95,541 | 1.29 | $123,248 |
| 2022-10-03 | HILZINGER KURT J | director | P | 41,798 | 1.25 | $52,248 |
| 2022-09-30 | HILZINGER KURT J | director | P | 33,199 | 1.26 | $41,831 |
| 2022-09-29 | HILZINGER KURT J | director | P | 13,800 | 1.19 | $16,422 |
| 2022-06-21 | Dagnon Terry | officer | P | 10,000 | 1.05 | $10,500 |
| 2022-06-21 | TRENARY C RUSSELL III | director | P | 19,925 | 1.06 | $21,121 |
| 2022-04-21 | Sukhtian Ghiath M.; GMS Ventures & Investments | director | J | 27,982,529 | — | — |
| 2022-04-21 | Sukhtian Faisal Ghiath; GMS Ventures & Investments | director | J | 27,982,529 | — | — |
| 2022-04-21 | BioLexis Pte Ltd. | ten percent owner | J | 27,982,529 | — | — |
| 2022-03-01 | HILZINGER KURT J | director | P | 27,708 | 1.69 | $46,827 |
| 2022-02-28 | HILZINGER KURT J | director | P | 6,000 | 1.6 | $9,600 |
| 2022-02-24 | HILZINGER KURT J | director | P | 41,160 | 1.46 | $60,094 |
| 2022-02-23 | HILZINGER KURT J | director | P | 79,535 | 1.44 | $114,530 |
| 2022-02-22 | HILZINGER KURT J | director | P | 95,597 | 1.49 | $142,440 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.